VolitionRx Limited (AMEX:VNRX) Q4 2023 Earnings Call Transcript March 26, 2024 VolitionRx Limited isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, ladies and gentlemen, and thank you for standing by. Welcome to VolitionRx Limited Fourth Quarter and Full […]
Ovarian cancer drug RC88 by RemeGen received FDA approval for Phase 2 clinical trials. Gynecologic oncologist Dr. Brian Slomovitz and other experts weigh in on the drug's potential.
Ovarian cancer treatment on fast track for FDA approval as chemo alternatives emerge: 'We're making progress' yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Ovarian cancer treatment on fast track for FDA approval as chemo alternatives emerge: 'We're making progress' wfin.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wfin.com Daily Mail and Mail on Sunday newspapers.